- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/20 - Pills, lozenges or tablets
Patent holdings for IPC class A61K 9/20
Total number of patents in this class: 14653
10-year publication summary
|
1257
|
1176
|
1293
|
1282
|
1264
|
1109
|
1058
|
1028
|
1095
|
641
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10262 |
142 |
| Sanovel Ilac Sanayi ve Ticaret A.S. | 301 |
142 |
| Fertin Pharma A/S | 285 |
133 |
| Antecip Bioventures II LLC | 374 |
116 |
| Axsome Therapeutics, Inc. | 381 |
109 |
| Boehringer Ingelheim International GmbH | 4493 |
99 |
| VeraDermics Inc. | 109 |
91 |
| Takeda Pharmaceutical Company Limited | 2712 |
82 |
| ratiopharm GmbH | 294 |
80 |
| Synthon BV | 310 |
80 |
| Gilead Sciences, Inc. | 2222 |
78 |
| Daiichi Sankyo Company, Limited | 1890 |
75 |
| Hanmi Pharm. Co., Ltd. | 601 |
72 |
| Merck Patent GmbH | 5728 |
70 |
| Purdue Pharma L.P. | 486 |
66 |
| Vertex Pharmaceuticals Incorporated | 1582 |
65 |
| Hoffmann-La Roche Inc. | 3793 |
62 |
| AstraZeneca AB | 2814 |
62 |
| Novo Nordisk A/S | 2279 |
62 |
| Otsuka Pharmaceutical Co., Ltd. | 1502 |
55 |
| Other owners | 12912 |